Venclexta costs $15,000+ per month. Save with copay assistance, patient programs, and discounts to cut your costs in 2026.
Let's start with the number that probably brought you here: Venclexta (Venetoclax) costs approximately $15,000 to $16,000 per month for the standard 400 mg daily dose. That's roughly $180,000 to $192,000 per year. Individual 100 mg tablets run about $131 to $139 each.
Those numbers are staggering, and for patients dealing with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML), the cost of treatment can feel like a second diagnosis.
The good news? Most patients don't actually pay anything close to the sticker price. Between manufacturer programs, copay assistance, patient assistance foundations, and insurance coverage strategies, there are real ways to bring your out-of-pocket cost down significantly — sometimes to $0.
Here's everything you need to know about saving money on Venclexta in 2026.
Without any insurance or discount program, here's what you're looking at:
There is no generic version of Venclexta available as of 2026, so the brand-name price is the only option at the pharmacy counter.
For patients with AML, the ramp-up is shorter (4 days to reach 400 mg), but the ongoing monthly cost is the same once you reach maintenance dosing.
This is the single most impactful program for commercially insured patients. Here's what it offers:
How to enroll:
Who qualifies: Patients with commercial (private) insurance. This program is not available for patients on Medicare, Medicaid, TRICARE, or other government-funded insurance programs (federal law prohibits manufacturer copay assistance for these patients).
If you are uninsured or underinsured and meet income eligibility criteria, the Genentech Patient Foundation may provide Venclexta at no cost.
This is a true patient assistance program (PAP) — not a discount card. Qualifying patients receive the medication for free directly from the foundation.
How to apply:
If you're struggling with the cost and don't have adequate insurance, this should be your first call.
This is the umbrella support program run by AbbVie and Genentech specifically for Venclexta patients. It's a one-stop resource that can help with:
Your oncologist's office can enroll you, or you can learn more at genentech-access.com or abbvieaccess.com/brand/venclexta.
Several independent, non-profit foundations provide copay assistance for patients with blood cancers. These may help if you're on Medicare or other government insurance (where manufacturer copay cards can't be used):
Important note: Foundation funds are limited and can run out. Apply as early as possible and check back if a fund is temporarily closed.
Using your insurer's in-network specialty pharmacy can reduce your copay compared to out-of-network options. Call the number on your insurance card to find out which specialty pharmacy your plan prefers.
Some insurance plans use "copay accumulator" or "copay maximizer" programs that prevent manufacturer copay assistance from counting toward your deductible or out-of-pocket maximum. If your plan does this, talk to VENCLEXTA Access Solutions — they may be able to help you navigate this issue.
If you know you'll be on Venclexta long-term (particularly for CLL/SLL maintenance), review your insurance options during open enrollment. Look for plans with:
The right plan can save you thousands of dollars over the course of treatment.
If you're on Medicare and have limited income, the Medicare Extra Help program can reduce your prescription drug costs significantly. Contact Medicare at 1-800-633-4227 or visit medicare.gov to see if you qualify.
Traditional discount cards like GoodRx and SingleCare are designed for common medications available at retail pharmacies. Because Venclexta is a specialty drug that costs $15,000+ per month and is only available through specialty pharmacies, these discount cards generally do not provide meaningful savings for this medication.
Your best options remain the manufacturer programs (Genentech Co-pay Assistance and Patient Foundation) and independent foundations listed above.
Venclexta's price tag is daunting, but the financial assistance landscape for this medication is actually quite robust. Between manufacturer programs, independent foundations, and insurance optimization strategies, most patients can significantly reduce — or even eliminate — their out-of-pocket costs.
Don't let the sticker price stop you from getting the treatment you need. Start with VENCLEXTA Access Solutions, explore the programs above, and work with your oncologist's office to find the best path forward.
For more information, see our other Venclexta guides:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
